Carlson Capital Management Exact Sciences Corp Transaction History

Carlson Capital Management

  • $1.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 27, 2020
SELL
$37.9 - $104.44 $130,451 - $359,482
-3,442 Closed
0 $0
Q4 2019

Jan 27, 2020
BUY
$77.66 - $99.74 $77,660 - $99,740
1,000 Added 40.95%
3,442 $318,000
Q3 2019

Oct 29, 2019
BUY
$90.37 - $122.49 $220,683 - $299,120
2,442 New
2,442 $221,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Carlson Capital Management Portfolio

Follow Carlson Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Carlson Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email